Barrett's metaplasia and colonic neoplasms: A significant association in a 203,534-patient study

Digestive Diseases and Sciences

Volumn 58, Issue 7, 2013, Pages 2046-2051

  Sonnenberg, Amnon ^a,b   Genta, Robert M ^c,d,e  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MIRACA LIFE SCIENCES   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Barrett's esophagus; Colon polyps; Epidemiology of gastrointestinal disease; Gastroesophageal reflux disease; Helicobacter pylori

Indexed keywords

ADENOMA; ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; COLON ADENOCARCINOMA; COLON TUMOR; COLONOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; VILLOUS ADENOMA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK;

EID: 84879844622     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2565-5     Document Type: Article

References (28)

1. Sontag SJ, Schnell TG, Chejfec G, et al. Barrett's oesophagus and colonic tumours. Lancet. 1985;1:946-949.
2. Howden CW, Hornung CA. A systematic review of the association between Barrett's esophagus and colon neoplasms. Am J Gastroenterol. 1995;90:1814-1819.
3. Siersema PD, Yu S, Sahbaie P, et al. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc. 2006;63:581-586.
4. Bollschweiler E, Schloesser T, Leers J, Vallböhmer D, Schäfer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009;52:299-304.
5. de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett's esophagus: a Dutch population-based study. Am J Gastroenterol. 2010;105:77-83.
6. Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM. The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50-80 years old. Am J Gastroenterol. 1997;92:592-596.
7. Laitakari R, Laippala P, Isolauri J. Barrett's oesophagus is not a risk factor for colonic neoplasia: a case-control study. Ann Med. 1995;27:499-502.
8. Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut. 1999;44:819-821.
9. Murphy SJ, Anderson LA, Mainie I, et al. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus. Scand J Gastroenterol. 2005;40:1449-1453 (erratum in: Scand J Gastroenterol. 2006;41:247).
10. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol. 2004;39:680-685.
11. Schouten LJ, Steevens J, Huysentruyt CJ, et al. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2011;9:754-761.
12. Cook MB, Wild CP, Everett SM, et al. Risk of mortality and cancer incidence in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007;16:2090-2096.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
14. Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733-1741.
15. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12:1-9.
16. Sonnenberg A, Amorosi LS, Lacey MJ, Lieberman DA. Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. Gastrointest Endosc. 2008;67:489-496.
17. Sontag S. The Colono-Barrett relationship: a tie that will not die. Gastrointest Endosc. 2006;63:587-589.
18. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901-909.
19. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007;133:34-41.
20. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8:340-347.
21. Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15:3329-3340.
22. McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34:146-165.
23. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998;115:275-280.
24. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
25. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008;123:1422-1428.
26. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011;140:1084-1091.
27. Wani S, Falk G, Hall M, et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220-227.
28. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595.